Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
OZURDEX endophthalmitis is a rare and potentially very serious pathology. Different treatments can be carried out early and change the functional prognosis of the patient.
- EligibilityCriteria: Inclusion Criteria:  Patient who had endophtalmitis following an OZURDEX implant injection within 2 months  Exclusion Criteria:  Intra oculaire procedure in the interval between the injection of OZURDEX and endophtalmitis - HealthyVolunteers: No - Gender: All - StdAgeList: Child, Adult, Older Adult - StudyPopulation: Patients treated by Dr Garcin and Pr Thuret CHU of Saint Etienne in the context of post-OZURDEX endophthalmitis - SamplingMethod: Non-Probability Sample